# Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

Study · id `cardio:ct-nct02830152` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02830152](<https://clinicaltrials.gov/study/NCT02830152>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02830152

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 750 participants.

## Technical summary

Registry record NCT02830152. Randomized; single masking; primary purpose prevention. Start 2017-05-03 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 750 participants (planned count; ClinicalTrials.gov record NCT02830152, source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)
- Started: 2017-05-03 (actual) (ClinicalTrials.gov record NCT02830152, source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT02830152, source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT02830152, source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)
- Countries: Denmark; Finland; Norway; Sweden (ClinicalTrials.gov record NCT02830152, source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02830152-2024-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage
- Condition: Atrial Fibrillation
- Condition: Stroke
- Condition: Intracerebral Hemorrhage
- Intervention (Device): LAAO
- Intervention (Drug): Medical Therapy
- Lead sponsor: Karolinska Institutet
- Lead sponsor class: OTHER
- Collaborator: Abbott Medical Devices
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Karolinska Institutet (`cardio:org-karolinska-institutet`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 106f81ae7a0faff9968208846d2e8a7362ee6b354c28da51272f45158a0e8286
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
